12-111565579-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372574.1(ATXN2):​c.252-9660C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.376 in 151,944 control chromosomes in the GnomAD database, including 14,919 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 14919 hom., cov: 32)

Consequence

ATXN2
NM_001372574.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.730

Publications

12 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.878 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372574.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
NM_001372574.1
MANE Select
c.252-9660C>A
intron
N/ANP_001359503.1
ATXN2
NM_002973.4
c.252-9660C>A
intron
N/ANP_002964.4
ATXN2
NM_001310121.1
c.-64-9660C>A
intron
N/ANP_001297050.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
ENST00000673436.1
MANE Select
c.252-9660C>A
intron
N/AENSP00000500925.1
ATXN2
ENST00000550104.5
TSL:1
c.732-9660C>A
intron
N/AENSP00000446576.2
ATXN2
ENST00000608853.5
TSL:1
c.252-9660C>A
intron
N/AENSP00000476504.1

Frequencies

GnomAD3 genomes
AF:
0.376
AC:
57029
AN:
151826
Hom.:
14881
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.685
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.331
Gnomad ASJ
AF:
0.115
Gnomad EAS
AF:
0.900
Gnomad SAS
AF:
0.367
Gnomad FIN
AF:
0.175
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.206
Gnomad OTH
AF:
0.361
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.376
AC:
57131
AN:
151944
Hom.:
14919
Cov.:
32
AF XY:
0.375
AC XY:
27852
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.685
AC:
28402
AN:
41446
American (AMR)
AF:
0.331
AC:
5045
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
398
AN:
3468
East Asian (EAS)
AF:
0.900
AC:
4671
AN:
5190
South Asian (SAS)
AF:
0.367
AC:
1759
AN:
4798
European-Finnish (FIN)
AF:
0.175
AC:
1845
AN:
10538
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.206
AC:
14013
AN:
67948
Other (OTH)
AF:
0.358
AC:
753
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1419
2838
4258
5677
7096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.250
Hom.:
7482
Bravo
AF:
0.407
Asia WGS
AF:
0.568
AC:
1975
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.6
DANN
Benign
0.72
PhyloP100
-0.73
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs616513; hg19: chr12-112003383; API